» Auto updated continuously
• Source limited to: Yahoo Finance
| 2022-08-08 20:05 |
TANGER REPORTS SECOND QUARTER RESULTS... Tanger Factory Outlet Centers, Inc. (NYSE:SKT), a leading owner and operator of upscale open-air outlet centers, today reported financial results and operating metrics for the three and six months ended June 30, 2022.... |
|
| 2022-08-08 20:05 |
PRA Group Reports Second Quarter 2022 Results... PRA Group, Inc. (Nasdaq: PRAA) (the... |
|
| 2022-08-08 20:05 |
Switch Announces Second Quarter 2022 Financial Results... Switch, Inc. (NYSE: SWCH) (... |
|
| 2022-08-08 20:05 |
Sitio Royalties Reports Second Quarter 2022 Operational and Financial Results... DENVER, August 08, 2022--Sitio Royalties Corp. (NYSE: STR) (... |
|
| 2022-08-08 20:05 |
Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference... PALO ALTO, Calif., August 08, 2022--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit Conference in Dana Point, CA.... |
|
| 2022-08-08 20:05 |
CURO Group Holdings Corp. Announces Second Quarter 2022 Financial Results... WICHITA, Kan., August 08, 2022--CURO Group Holdings Corp. (NYSE: CURO) (... |
|
| 2022-08-08 20:05 |
MediWound Enhances Its Board and Executive Leadership Team... Mr. Nachum Shamir appointed as Chairman of the Board Dr. Robert Snyder appointed as Chief Medical Officer YAVNE, Israel, Aug. 08, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the "Company"), a fully-integrated biopharmaceutical company ... |
|
| 2022-08-08 20:05 |
Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2022... RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery,... |
|
| 2022-08-08 20:05 |
Apellis Pharmaceuticals Reports Second Quarter 2022 Financial Results... Received U.S. FDA filing acceptance of NDA with Priority Review designation for intravitreal pegcetacoplan for treatment of geographic atrophy; PDUFA target action date of November 26, 2022Achieved $15.7 million in Q2 2022 EMPAVELI (pegcetacoplan) U.S. ne... |
|
| 2022-08-08 20:05 |
Metropolitan Issues Statement on U.S. Senate Passage of Inflation Reduction Act, Including Drought Relief Funding... LOS ANGELES, August 08, 2022--Adel Hagekhalil, general manager of the Metropolitan Water District of Southern California, and Gloria D. Gray, chairwoman of Metropolitan's Board of Directors, issue the following statement on the U.S. Senate's passa... |